Want to see TSE:ASTI full AI Analyst Report?

Aquarius Surgical Technologies (ASTI) Price & Analysis

1 Followers

ASTI Stock Chart & Stats

C$0.01

C$0.00(0.00%)

At close: Jun 22 4:00 PM EDT

C$0.01

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.02

Previous CloseN/A

Volume10.50K

Average Volume (3M)6.90K

Market Cap

C$551.98K

Enterprise ValueC$0.84

Total Cash (Recent Filing)C$44.51K

Total Debt (Recent Filing)C$6.94M

Price to Earnings (P/E)―

Beta0.26

Next Earnings

Sep 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding27,599,173

10 Day Avg. Volume4,405

30 Day Avg. Volume6,901

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)-0.06

Price to Sales (P/S)4.53

P/FCF Ratio-3.56

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue ReboundThe year-over-year revenue rebound indicates some renewed demand or commercial traction. Although the base remains small, sustained growth could improve operating leverage and support a longer-term recovery if it continues.

Narrower Net LossA narrower loss is an incremental sign of operating improvement and may indicate that cost controls or business stabilization are having some effect. Continued progress would reduce the distance to break-even, although profitability remains remote.

Reduced Cash BurnThe materially smaller operating cash outflow suggests improved near-term cash discipline relative to the prior year. If maintained alongside revenue growth, this could extend liquidity and reduce the pace of external funding needs.

Bears Say

Small, Volatile Revenue BaseRevenue remains very small and substantially below earlier periods, showing limited scale and weak business consistency. This restricts operating leverage, makes fixed costs harder to absorb, and leaves the company vulnerable to further demand volatility.

Deep Operating UnprofitabilityThe extreme net margin and continuing operating losses show that the current revenue base cannot support the cost structure. Without substantial growth or restructuring, ongoing losses will continue consuming capital and impede sustainable business development.

Negative Equity And High DebtNegative equity combined with debt exceeding total assets indicates severe balance-sheet fragility. This limits financial flexibility and increases refinancing, dilution, and creditor-dependence risks, potentially constraining investment in products and operations.

ASTI FAQ

What was Aquarius Surgical Technologies Inc.’s price range in the past 12 months?

Aquarius Surgical Technologies Inc. lowest stock price was C$0.01 and its highest was C$0.02 in the past 12 months.

What is Aquarius Surgical Technologies Inc.’s market cap?

Aquarius Surgical Technologies Inc.’s market cap is C$551.98K.

When is Aquarius Surgical Technologies Inc.’s upcoming earnings report date?

Aquarius Surgical Technologies Inc.’s upcoming earnings report date is Sep 01, 2026 which is in 9 days.

How were Aquarius Surgical Technologies Inc.’s earnings last quarter?

Currently, no data Available

Is Aquarius Surgical Technologies Inc. overvalued?

According to Wall Street analysts Aquarius Surgical Technologies Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aquarius Surgical Technologies Inc. pay dividends?

Aquarius Surgical Technologies Inc. does not currently pay dividends.

What is Aquarius Surgical Technologies Inc.’s EPS estimate?

Aquarius Surgical Technologies Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aquarius Surgical Technologies Inc. have?

Aquarius Surgical Technologies Inc. has 27,599,173 shares outstanding.

What happened to Aquarius Surgical Technologies Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Aquarius Surgical Technologies Inc.?

Currently, no hedge funds are holding shares in TSE:ASTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings throughout Canada and the United States. The company's core offering comprises sophisticated medical laser systems, catering to a diverse array of specialties such as urology, gynecology, ophthalmology, thoracic surgery, otolaryngology (ENT), cardiovascular procedures, and neurosurgery. Incorporated in 1986, the Toronto, Canada-based firm was previously known as Aquarius Coatings Inc.